Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 100-104

  Feroze, Usama ^a   Molnar, Miklos Z ^a   Dukkipati, Ramanath ^a   Kovesdy, Csaba P ^b   Kalantar Zadeh, Kamyar ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CYTOKINE; PARATHYROID HORMONE;

BLOOD; CACHEXIA; CHRONIC KIDNEY FAILURE; HUMAN; INFLAMMATION; MALNUTRITION; METHODOLOGY; PROTEIN CALORIE MALNUTRITION; RENAL REPLACEMENT THERAPY; REVIEW; SYNDROME;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CACHEXIA; CYTOKINES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALNUTRITION; PARATHYROID HORMONE; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; SYNDROME;

EID: 78650680957     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.10.006     Document Type: Review

References (32)

1. Kalantar-Zadeh K., Shah A., Duong U., et al. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, alkaline phosphatase and minerals. Kidney Int 2010, 78(Suppl 117):S10-S21.
2. Dukkipati R., Kovesdy C.P., Colman S., et al. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 2010, 20:243-254.
3. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006, 70:771-780.
4. Kalantar-Zadeh K., Kopple J.D. Response to 'adynamic bone disease and MICS' (letter reply). Kidney Int 2007, 71:1327.
5. Ni Z., Smogorzewski M., Massry S.G. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 1994, 135:1837-1844.
6. Kovesdy C.P., Ahmadzadeh S., Anderson J.E., et al. Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:1024-1029.
7. Sanchez-Gonzalez M.C., Lopez-Barea F., Bajo M.A., et al. Serum albumin levels, an additional factor implicated in hyperparathyroidism outcome in peritoneal dialysis: a prospective study with paired bone biopsies. Adv Perit Dial 2006, 22:198-202.
8. Carlstedt E., Ridefelt P., Lind L., et al. Interleukin-6 induced suppression of bovine parathyroid hormone secretion. Biosci Rep 1999, 19:35-42.
9. Bologa R.M., Levine D.M., Parker T.S., et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998, 32:107-114.
10. Nielsen P.K., Rasmussen A.K., Butters R., et al. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Commun 1997, 238:880-885.
11. Akizawa T., Kinugasa E., Kurihara R., et al. Risk factors for the development of parathyroid hormone deficiency in dialysis patients. J Am Soc Nephrol 1998, 9:561A.
12. Avram M., Sreedhara R., Oo K., et al. Prognostic value of enrollment nutritional markers including novel predictors PTH and prealbumin in hemodialysis patients: 12 years of follow-up. J Am Soc Nephrol 1999, 10:272A.
13. Avram M., Sreedhara R., Henry A., et al. Correlates of survival in peritoneal dialysis: 15 years of follow-up. J Am Soc Nephrol 1999, 10:311A.
14. Fukagawa M., Akizawa T., Kurokawa K. Is aplastic osteodystrophy a disease of malnutrition?. Curr Opin Nephrol Hypertens 2000, 9:363-367.
15. Molnar M.Z., Keszei A., Czira M.E., et al. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis 2010, 56:102-111.
16. Mehrotra R., Supasyndh O., Berman N., et al. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake. J Ren Nutr 2004, 14:134-142.
17. Kovesdy C.P., Kalantar-Zadeh K. Do genes allow inflammation to kill or not to kill?. J Am Soc Nephrol 2009, 20:1429-1431.
18. Nakai S., Akiba T., Kazama J., et al. Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial 2008, 12:49-54.
19. National Kidney Foundation: Kidney Disease-Dialysis Outcome Quality Initiative: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(Suppl 3):S1-S202.
20. Regidor D., Kovesdy C., Mehrotra R., et al. Mortality predictability of serum alkaline phosphatase in maintenance hemodialysis patients. J Am Soc Nephrol 2008, 19:2193-2203.
21. Drechsler C., Krane V., Grootendorst D.C., et al. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Nephrol Dial Transplant 2009, 24:3151-3157.
22. Kovesdy C.P., Anderson J.E., Derose S.F., Kalantar-Zadeh K. Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:973-988.
23. Wolf M., Betancourt J., Chang Y., et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008, 19:1379-1388.
24. Rambod M., Bross R., Zitterkoph J., et al. Association of malnutrition-inflammation score with quality of life and mortality in maintenance hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009, 53:298-309.
25. Rambod M., Kovesdy C.P., Bross R., Kopple J.D., Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008, 88:1485-1494.
26. Coen G. Adynamic bone disease: an update and overview. J Nephrol 2005, 18:117-122.
27. Mucsi I., Hercz G. Adynamic bone disease: pathogenesis, diagnosis and clinical relevance. Curr Opin Nephrol Hypertens 1997, 6:356-361.
28. Haris A., Sherrard D.J., Hercz G. Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int 2006, 70:931-937.
29. Sanchez C.P. Adynamic bone revisited: is there progress?. Perit Dial Int 2006, 26:43-48.
30. Miller J.E., Kovesdy C.P., Norris K.C., Mehrotra R., Nissenson A.R., Kopple J.D., Kalantar-Zadeh K. Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients. Am J Nephrol 2010, 32:403-413.
31. Kovesdy C.P., Ahmadzadeh S., Anderson J.E., et al. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 2008, 73:1296-1302.
32. Kalantar-Zadeh K., Miller J.E., Kovesdy C.P., et al. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D and survival in hemodialysis patients. J Bone Miner Res 2010 Jul 1, [Epub ahead of print].